Benoit Gourdier - 20 Feb 2025 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Bioscience Production
Signature
/s/ Scott Baker, as Attorney-in-Fact
Issuer symbol
AVTR
Transactions as of
20 Feb 2025
Transactions value $
-$49,167
Form type
4
Filing time
24 Feb 2025, 17:31:13 UTC
Previous filing
04 Oct 2024
Next filing
12 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Award $0 +35.7K +86.75% $0.00 76.9K 20 Feb 2025 Direct F1
transaction AVTR Common Stock Tax liability -$49.2K -2.84K -3.69% $17.30 74.1K 23 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTR Stock Options (Right to Buy) Award $0 +86.6K $0.00 86.6K 20 Feb 2025 Common Stock 86.6K $17.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted stock units that vest in three equal annual installments beginning on February 20, 2026.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
F3 Reflects a grant of stock options that vest in three equal annual installments beginning on February, 20, 2026.